Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers

Pornchai Sithisarankul, Brian S Schwartz, Byung Kook Lee, Karl T. Kelsey, Paul Timothy Strickland

Research output: Contribution to journalArticle

Abstract

The first intermediate substrate in the heme synthetic pathway, 5- aminolevulinic acid (ALA), is neurotoxic in animal models and may be responsible for some of the adverse neurologic outcomes in lead poisoning and porphyria in adult humans. ALA is a substrate for the enzyme aminolevulinic acid dehydratase (ALAD; EC 4.2.1.24), which is encoded by the ALAD gene containing 2 co-dominant alleles, 1 and 2. We measured plasma ALA (ALAP) and urinary ALA (ALAU) in 65 Korean lead workers, of whom 44 were homozygous for ALAD1 (ALAD1-1 genotype) and 21 were heterozygous for ALAD (ALAD1-2 genotype). ALAP in subjects with the ALAD1-1 genotype was significantly higher than in those with the ALAD1-2 genotype (Wilcoxon rank sum test, P = 0.01). No difference between ALAD genotypes was found for age, zinc protoporphyrin (ZPP), blood lead levels (PbB), ALAU, or ALAU adjusted for creatinine. ALAP was significantly correlated with ZPP (Spearman's r = 0.38, P = 0.002) and with PbB (r = 0.34, P = 0.006), and marginally with employment duration (r = 0.22, P = 0.08). ALAP remained significantly elevated (P = 0.032) in ALAD1-1 subjects after adjustment for PbB and age by multiple linear regression. These results suggest that ALAD1-1 subjects respond differently and may be more susceptible than ALAD1-2 subjects to the ALA- mediated neurotoxic effects of lead.

Original languageEnglish (US)
Pages (from-to)15-20
Number of pages6
JournalAmerican Journal of Industrial Medicine
Volume32
Issue number1
DOIs
StatePublished - Jul 1997

Fingerprint

Porphobilinogen Synthase
Aminolevulinic Acid
Genotype
Nonparametric Statistics
Porphyrias
Lead Poisoning
Heme
Nervous System
Linear Models
Creatinine
Animal Models
Alleles
Lead
pelamitoxin
Enzymes
Genes

Keywords

  • aminolevulinic acid
  • blood lead
  • genotype
  • lead-exposed workers
  • neurotoxin

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. / Sithisarankul, Pornchai; Schwartz, Brian S; Lee, Byung Kook; Kelsey, Karl T.; Strickland, Paul Timothy.

In: American Journal of Industrial Medicine, Vol. 32, No. 1, 07.1997, p. 15-20.

Research output: Contribution to journalArticle

@article{53745a41544a4d4098f2134ab0fa20b1,
title = "Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers",
abstract = "The first intermediate substrate in the heme synthetic pathway, 5- aminolevulinic acid (ALA), is neurotoxic in animal models and may be responsible for some of the adverse neurologic outcomes in lead poisoning and porphyria in adult humans. ALA is a substrate for the enzyme aminolevulinic acid dehydratase (ALAD; EC 4.2.1.24), which is encoded by the ALAD gene containing 2 co-dominant alleles, 1 and 2. We measured plasma ALA (ALAP) and urinary ALA (ALAU) in 65 Korean lead workers, of whom 44 were homozygous for ALAD1 (ALAD1-1 genotype) and 21 were heterozygous for ALAD (ALAD1-2 genotype). ALAP in subjects with the ALAD1-1 genotype was significantly higher than in those with the ALAD1-2 genotype (Wilcoxon rank sum test, P = 0.01). No difference between ALAD genotypes was found for age, zinc protoporphyrin (ZPP), blood lead levels (PbB), ALAU, or ALAU adjusted for creatinine. ALAP was significantly correlated with ZPP (Spearman's r = 0.38, P = 0.002) and with PbB (r = 0.34, P = 0.006), and marginally with employment duration (r = 0.22, P = 0.08). ALAP remained significantly elevated (P = 0.032) in ALAD1-1 subjects after adjustment for PbB and age by multiple linear regression. These results suggest that ALAD1-1 subjects respond differently and may be more susceptible than ALAD1-2 subjects to the ALA- mediated neurotoxic effects of lead.",
keywords = "aminolevulinic acid, blood lead, genotype, lead-exposed workers, neurotoxin",
author = "Pornchai Sithisarankul and Schwartz, {Brian S} and Lee, {Byung Kook} and Kelsey, {Karl T.} and Strickland, {Paul Timothy}",
year = "1997",
month = "7",
doi = "10.1002/(SICI)1097-0274(199707)32:1<15::AID-AJIM2>3.0.CO;2-Q",
language = "English (US)",
volume = "32",
pages = "15--20",
journal = "American Journal of Industrial Medicine",
issn = "0271-3586",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers

AU - Sithisarankul, Pornchai

AU - Schwartz, Brian S

AU - Lee, Byung Kook

AU - Kelsey, Karl T.

AU - Strickland, Paul Timothy

PY - 1997/7

Y1 - 1997/7

N2 - The first intermediate substrate in the heme synthetic pathway, 5- aminolevulinic acid (ALA), is neurotoxic in animal models and may be responsible for some of the adverse neurologic outcomes in lead poisoning and porphyria in adult humans. ALA is a substrate for the enzyme aminolevulinic acid dehydratase (ALAD; EC 4.2.1.24), which is encoded by the ALAD gene containing 2 co-dominant alleles, 1 and 2. We measured plasma ALA (ALAP) and urinary ALA (ALAU) in 65 Korean lead workers, of whom 44 were homozygous for ALAD1 (ALAD1-1 genotype) and 21 were heterozygous for ALAD (ALAD1-2 genotype). ALAP in subjects with the ALAD1-1 genotype was significantly higher than in those with the ALAD1-2 genotype (Wilcoxon rank sum test, P = 0.01). No difference between ALAD genotypes was found for age, zinc protoporphyrin (ZPP), blood lead levels (PbB), ALAU, or ALAU adjusted for creatinine. ALAP was significantly correlated with ZPP (Spearman's r = 0.38, P = 0.002) and with PbB (r = 0.34, P = 0.006), and marginally with employment duration (r = 0.22, P = 0.08). ALAP remained significantly elevated (P = 0.032) in ALAD1-1 subjects after adjustment for PbB and age by multiple linear regression. These results suggest that ALAD1-1 subjects respond differently and may be more susceptible than ALAD1-2 subjects to the ALA- mediated neurotoxic effects of lead.

AB - The first intermediate substrate in the heme synthetic pathway, 5- aminolevulinic acid (ALA), is neurotoxic in animal models and may be responsible for some of the adverse neurologic outcomes in lead poisoning and porphyria in adult humans. ALA is a substrate for the enzyme aminolevulinic acid dehydratase (ALAD; EC 4.2.1.24), which is encoded by the ALAD gene containing 2 co-dominant alleles, 1 and 2. We measured plasma ALA (ALAP) and urinary ALA (ALAU) in 65 Korean lead workers, of whom 44 were homozygous for ALAD1 (ALAD1-1 genotype) and 21 were heterozygous for ALAD (ALAD1-2 genotype). ALAP in subjects with the ALAD1-1 genotype was significantly higher than in those with the ALAD1-2 genotype (Wilcoxon rank sum test, P = 0.01). No difference between ALAD genotypes was found for age, zinc protoporphyrin (ZPP), blood lead levels (PbB), ALAU, or ALAU adjusted for creatinine. ALAP was significantly correlated with ZPP (Spearman's r = 0.38, P = 0.002) and with PbB (r = 0.34, P = 0.006), and marginally with employment duration (r = 0.22, P = 0.08). ALAP remained significantly elevated (P = 0.032) in ALAD1-1 subjects after adjustment for PbB and age by multiple linear regression. These results suggest that ALAD1-1 subjects respond differently and may be more susceptible than ALAD1-2 subjects to the ALA- mediated neurotoxic effects of lead.

KW - aminolevulinic acid

KW - blood lead

KW - genotype

KW - lead-exposed workers

KW - neurotoxin

UR - http://www.scopus.com/inward/record.url?scp=0030924965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030924965&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0274(199707)32:1<15::AID-AJIM2>3.0.CO;2-Q

DO - 10.1002/(SICI)1097-0274(199707)32:1<15::AID-AJIM2>3.0.CO;2-Q

M3 - Article

C2 - 9131207

AN - SCOPUS:0030924965

VL - 32

SP - 15

EP - 20

JO - American Journal of Industrial Medicine

JF - American Journal of Industrial Medicine

SN - 0271-3586

IS - 1

ER -